Recruiting NA Hypertension

New treatment option for Hypertension

Official title Early Time-Restricted Eating in Older Adults With Hypertension

ClinicalTrials.gov ID: NCT07135505

What this study is testing

What it's testing
The purpose of this study is to find out how early time-restricted eating affects body rhythms and improves cardiometabolic health in older adults.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 60 and older

You may be able to join if

  • Consent to participate in the study
  • Men and women ≥ 60 years old
  • Average office systolic BP ≥130 mmHg
  • Self-reported ≥12 hours eating period per day of at least 5 days/week
  • Stable health history over the past 2 months

You likely can't join if

  • Fasting \>12 hours per day
  • Actively trying to lose weight by participating in formal weight loss program or significantly restricting calorie intake
  • Have lost ≥ 10 pounds in last 3 months
  • Unable to wake up at a regular time between 6-8 am
  • Perform overnight shift work more than 1day/week on average
  • Resting heart rate of \>120 beats per minute, systolic blood pressure \> 180 mmHg and/or diastolic blood pressure of \> 100 mmHg
See the full eligibility criteria
Who can join
  • Consent to participate in the study
  • Men and women ≥ 60 years old
  • Average office systolic BP ≥130 mmHg
  • Self-reported ≥12 hours eating period per day of at least 5 days/week
  • Stable health history over the past 2 months
What rules you out
  • Fasting \>12 hours per day
  • Actively trying to lose weight by participating in formal weight loss program or significantly restricting calorie intake
  • Have lost ≥ 10 pounds in last 3 months
  • Unable to wake up at a regular time between 6-8 am
  • Perform overnight shift work more than 1day/week on average
  • Resting heart rate of \>120 beats per minute, systolic blood pressure \> 180 mmHg and/or diastolic blood pressure of \> 100 mmHg
  • Have been diagnosed with diabetes
  • On insulin or diabetes medication
  • Unstable angina, heart attack or stroke in the past 3 months
  • Continuous use of supplemental oxygen to manage a chronic pulmonary condition or heart failure
  • Pregnant or breastfeeding
  • Rheumatoid arthritis, Parkinson's disease or currently on dialysis
  • Current diagnosis of a major psychiatric condition that would impair study participation
  • Severe gastrointestinal disease, major gastrointestinal surgery, or active gallstone disease
  • Active treatment for cancer in the past year
  • Taking medications that preclude fasting for 16 hours (e.g. must be taken with food at least 12 hours apart)

The study team makes the final eligibility decision.

Where it's taking place

  • Birmingham, Alabama, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Birmingham, Alabama, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.